Literature DB >> 6304770

Paralysis in nude mice caused by polyomavirus-induced vertebral tumors.

J S Harper, C J Dawe, B D Trapp, P E McKeever, M Collins, J L Woyciechowska, D L Madden, J L Sever.   

Abstract

Eighty-one of 95 BaLB/c nude mice infected intracranially with the LID strain of polyomavirus developed tumors of the vertebrae which compressed the spinal cord or peripheral nerves and produced paralysis. Wallerian degeneration was the only pathological alteration found in the nervous system of polyoma-infected mice. While polyomavirus was demonstrated in the brain and spinal cord by viral isolation and immunoperoxidase staining, no evidence of a primary demyelinating process was found. The disease produced in the present study is not a satisfactory animal model of progressive multifocal leukoencephalopathy.

Entities:  

Mesh:

Year:  1983        PMID: 6304770

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  5 in total

1.  Systemic polyomavirus genome increase and dissemination of capsid-defective genomes in mammary gland tumor-bearing mice.

Authors:  J J Wirth; L Chen; M M Fluck
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Immunological elimination of infected cells as the candidate mechanism for tumor protection in polyomavirus-infected mice.

Authors:  J J Wirth; M M Fluck
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Generation of antiviral major histocompatibility complex class I-restricted T cells in the absence of CD8 coreceptors.

Authors:  Nicolas P Andrews; Christopher D Pack; Aron E Lukacher
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

Review 4.  The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy.

Authors:  Elizabeth L Frost; Aron E Lukacher
Journal:  Front Immunol       Date:  2015-01-05       Impact factor: 7.561

Review 5.  Understanding polyomavirus CNS disease - a perspective from mouse models.

Authors:  Katelyn N Ayers; Sarah N Carey; Aron E Lukacher
Journal:  FEBS J       Date:  2021-07-02       Impact factor: 5.622

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.